Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-303864
Filing Date
2022-12-13
Accepted
2022-12-13 16:51:13
Documents
1
Group Members
BLACKSTONE CLARUS GP L.L.C.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I L.P.BLACKSTONE HOLDINGS I/II GP L.L.C.BLACKSTONE LIFE SCIENCES ASSOCIATES V (CYM) L.L.C.BXLS V - AUTOBAHN L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d435624dsc13da.htm SC 13D/A 155721
  Complete submission text file 0001193125-22-303864.txt   157984
Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 (212) 583-5000
Blackstone Inc. (Filed by) CIK: 0001393818 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice

Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90550 | Film No.: 221460253
SIC: 2836 Biological Products, (No Diagnostic Substances)